CD44 and CD133 cancer stem cell markers as indicators for aggressive ovarian tumours

被引：0
|
作者：
Jovanovic, L.
Sosic-Jurjevic, B.
Cirkovic, A.
Dragicevic, S.
Filipovic, B.
Milenkovic, S.
Dugalic, S.
Gojnic-Dugalic, M.
Nikolic, A.
机构：
来源：
VIRCHOWS ARCHIV | 2024年 / 485卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-10-05
引用
收藏
页码：S285 / S285
页数：1
相关论文
共 50 条
  • [21] Tumour stem cell markers CD133 and CD44 are useful prognostic factors after surgical resection of pancreatic neuroendocrine tumours
    Sun, Zhonghai
    Li, Dezhi
    Wu, Hongmei
    Hou, Baohua
    ONCOLOGY LETTERS, 2020, 20 (06)
  • [22] Expressions of Putative Cancer Stem Cell Markers, CD44 and CD133, are Correlated with Pathological Tumour Stage in Gastric Adenocarcinoma
    Duzcu, Selma Erdogan
    Astarci, Hesna Muzeyyen
    Tunc, Nur
    Boran, Cetin
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2021, 31 (05): : 553 - 558
  • [23] CD133 and CD44 Cell surface markers do not identify cancer stem cells in primary human gastric tumors
    Rocco, Alba
    Liguori, Eleonora
    Pirozzi, Giuseppe
    Tirino, Virginia
    Compare, Debora
    Franco, Renato
    Tatangelo, Fabiana
    Palaia, Raffaele
    D'Armiento, Francesco Paolo
    Pollastrone, Giorgia
    Affuso, Andrea
    Bottazzi, Enrico Coppola
    Masone, Stefania
    Persico, Giovanni
    Nardone, Gerardo
    JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (06) : 2686 - 2693
  • [24] CD44 and CD133 aptamer directed nanocarriers for cancer stem cells targeting
    Grover, Rakshita
    Drall, Sahil
    Poonia, Neelam
    Jain, Gaurav Kumar
    Aggarwal, Geeta
    Lather, Viney
    Kesharwani, Prashant
    Pandita, Deepti
    Goyal, Ramesh K.
    EUROPEAN POLYMER JOURNAL, 2023, 183
  • [25] Expression of CD44 and CD133 markers in regional metastases from breast cancer.
    Sagakyants, Aleksandr B.
    Ulianova, Elena P.
    Zlatnik, Elena Yu
    Novikova, Inna A.
    Shulgina, Oksana G.
    Karnaukhov, Nikolay S.
    Kuznetsova, Marina A.
    Petriashvili, Inna R.
    Gaysultanova, Yakha S.
    Vladimirova, Liubov Yu
    Shatova, Iuliana S.
    Vashchenko, Larisa N.
    Lisutin, Aleksandr E.
    Kit, Oleg, I
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] Expression of putative cancer stem cell markers CD44 and CD133 in prostate carcinomas: A tissue microarray study of Iranian patients
    Asgari, M.
    Kalantari, E.
    Nikpanah, S.
    Salarieh, N.
    Madjd, Z.
    VIRCHOWS ARCHIV, 2016, 469 : S227 - S228
  • [27] Prognostic impact of the expression of cancer stem cell markers CD166, CD44, EpCAM, ALDH1 and CD133 in colorectal cancer
    lezzi, Giandomenica
    Lugli, Alessandro
    Muraro, Manuele G.
    Mele, Valentina
    Hostettler, Isabel
    Tornillo, Luigi
    Carafa, Vincenza
    Spagnoli, Giulio C.
    Terracciano, Luigi
    Zlobec, Intl
    CANCER RESEARCH, 2010, 70
  • [28] Co-expression of CD44 and CD133 as cancer stem cells (CSC) markers in prostate cancer (PCa) tissue
    Puchinskaya, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1369 - S1369
  • [29] Expression of Stem Cell Markers, CD133 and CD44, in Pediatric Solid Tumors: A Study Using Tissue Microarray
    Mehrazma, Mitra
    Madjd, Zahra
    Kalantari, Elham
    Panahi, Mahshid
    Hendi, Alireza
    Shariftabrizi, Ahmad
    FETAL AND PEDIATRIC PATHOLOGY, 2013, 32 (03) : 192 - 204
  • [30] Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells
    Sahlberg, Sara Haggblad
    Spiegelberg, Diana
    Glimelius, Bengt
    Stenerlow, Bo
    Nestor, Marika
    PLOS ONE, 2014, 9 (04):
12345